Pfizer, BioNTech announce early positive data from SARS-CoV-2 trial
Pfizer Inc. and BioNTech SE announced preliminary data from the most advanced of four investigational vaccine candidates from their BNT162 mRNA-based vaccine program, Project…
Read More...
Read More...
